Amundi Asset Management US’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-601
Closed -$15K 1591
2020
Q3
$15K Hold
601
﹤0.01% 1502
2020
Q2
$11K Buy
601
+360
+149% +$7.09K ﹤0.01% 1535
2020
Q1
$3K Sell
241
-2,670
-92% -$76.6K ﹤0.01% 1578
2019
Q4
$111K Buy
+2,911
New +$87.2K ﹤0.01% 1555
2018
Q4
Sell
-6,735
Closed -$192K 1665
2018
Q3
$192K Buy
6,735
+2,005
+42% +$66.2K ﹤0.01% 1457
2018
Q2
$159K Hold
4,730
﹤0.01% 1438
2018
Q1
$115K Hold
4,730
﹤0.01% 1393
2017
Q4
$72K Buy
+4,730
New +$66.6K ﹤0.01% 1462

Other funds holding THC

Amundi Asset Management US's THC Position: Q4 2020 in Review

Amundi Asset Management US sold out of Tenet Healthcare (THC) in Q4 2020, closing a stake of 601 shares — an estimated $15K sold.

Amundi Asset Management US first reported a position in THC in Q4 2017 and held it in 8 quarters. The position peaked at $192K in Q3 2018. 278 funds tracked by Wall St. Rank hold THC as of Q4 2020.

  • Amundi Asset Management US reported no remaining Tenet Healthcare position as of Q4 2020 after selling out during the quarter.
  • Amundi Asset Management US sold 601 Tenet Healthcare shares in Q4 2020, an estimated $15K.
  • Amundi Asset Management US first reported a position in Tenet Healthcare in Q4 2017 and held it in 8 quarters.
  • Amundi Asset Management US's Tenet Healthcare position peaked at $192K in Q3 2018.
  • 278 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.